Related Experiment Video

Updated: Aug 15, 2026

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
13:50

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients

Published on: June 11, 2011

Characteristics of tuberculosis in HIV-infected patients: a case-control study

E Soriano1, J Mallolas, J M Gatell

  • 1Infectious Disease Unit, Hospital Clinic, University of Barcelona, Spain.

AIDS (London, England)
|December 1, 1988
PubMed

Insights

Human immunodeficiency virus (HIV) infection significantly alters tuberculosis presentation, often leading to extrapulmonary and disseminated forms, particularly in drug addicts. Treatment was effective, but side effects were common in HIV-positive patients.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Clinical Medicine

Background:

  • Tuberculosis (TB) is a major opportunistic infection in individuals with human immunodeficiency virus (HIV).
  • Understanding how HIV impacts TB clinical characteristics is crucial for diagnosis and management.

Purpose of the Study:

  • To investigate the clinical differences in tuberculosis presentation between HIV-seropositive and HIV-seronegative individuals.
  • To assess the treatment efficacy and side effects in HIV-infected TB patients.

Main Methods:

  • A comparative study of 65 HIV-seropositive TB patients and 65 matched HIV-seronegative TB controls.
  • Clinical characteristics, including TB localization and form, were analyzed.
  • Treatment outcomes and adverse events were monitored.

Main Results:

  • HIV-seropositive patients frequently presented with extrapulmonary (39%) and disseminated (11%) TB, unlike controls (0%).
  • Parenteral drug addiction was common (83%) among HIV-TB cases.
  • Treatment was effective, but side effects were significantly more frequent in HIV-positive patients (39% vs 22%).

Conclusions:

  • HIV infection profoundly modifies tuberculosis presentation, favoring extrapulmonary and disseminated forms, especially in drug users.
  • Short-course TB treatment appears effective but is associated with a higher incidence of side effects in HIV-infected individuals.

More Related Videos

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...